Phil is a well-known biostatistician with a long history supporting clinical trials. He was a member of the Biostatistics faculty at the Harvard School of Public Health and the Department of Surgery at Harvard Medical School where he was affiliated for over 25 years. He co-founded Boston Biostatistics which became Aptiv Solutions before it was acquired by ICON plc.
Phil has authored or co-authored over 180 peer-reviewed publications in the medical and statistical literature. He innovated a new study design used widely for medical devices (quasi-non-inferiority design). He has developed solutions for optimum timing of interim analysis, extending labeling for multiple endpoints, and devising composite endpoints and models for interim monitoring of adaptive studies.